This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Stocks to Watch: Amylin, Barclays, Lincare, BrightPoint (Update 1)

Stocks in this article: BMY AMLN BCS AAPL AYI

NEW YORK -- Bristol-Myers Squibb (BMY - Get Report) is purchasing diabetes drugmaker Amylin Pharmaceuticals (AMLN) in a deal valued at about $7 billion.

The companies said on Friday that Bristol-Myers would pay $31 a share in cash for San Diego-based Amylin. The deal includes Amylin's net debt and a payment obligation to Eli Lilly bringing the total value of the transaction to about $7 billion, the companies said.

The purchase price offers a 9.9% premium of to Amylin's closing share price Friday of $28.20.

Shares of Amylin rose 8.94% in premarket trading Monday to $30.72.

RIM: Berries Dying on the Vine


Barclays PLC (BCS) said Monday its chairman has resigned.

Marcus Agius departs following the bank's $453 million settlement of an investigation into alleged interest rate manipulation.

Regulators in the U.S. and the U.K. alleged that Barclays had submitted false data for setting the London interbank offered rate, or Libor, between 2005 and 2009. Agius has been chairman at Barclays since the beginning of 2007.

Barclays shares rose 3.79% in premarket trading Monday to $10.69.


Technology distributor Ingram Micro (IM) said Monday that it agreed to acquire wireless device distributor BrightPoint (CELL) for $840 million, including debt.

The offer of $9 a share is a 66% premium to BrightPint's closing price Friday of $5.41.

Shares of BrightPoint jumped 61.18% in premarket trading Monday to $8.72.


Germany's Linde agreed to buy Lincare Holdings (LNCR) for about $3.8 billion.

Under the deal, Linde will pay $41.50 a share for Lincare, a leader in the U.S. home respiratory market.

Lincare shares closed Friday at $34.02.

Shares of Lincare climbed 19.93% in premarket trading Monday to $40.80.


Apple (AAPL - Get Report) paid $60 million to Shenzhen Proview Technology to settle a dispute in China over ownership of the iPad name, a court announced Monday, according to a report from The Associated Press.

The deal removes a potential obstacle to sales of the iPad in China, a key market.

Apple shares ticked up $1.25, or 0.21%, in premarket trading Monday to $585.25.

Sirius XM Teetering on the Brink of Irrelevancy


Acuity Brands (AYI)is expected by analysts Monday to post third-quarter earnings of 79 cents a share on revenue $492 million.

AB InBev Gulps Corona Maker For $21.1 Billion

-- Written by Joseph Woelfel



>To contact the writer of this article, click here: Joseph Woelfel

>To submit a news tip, send an email to: tips@thestreet.com.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,678.70 +6.10 0.03%
S&P 500 2,057.09 +5.27 0.26%
NASDAQ 4,771.7630 +13.8840 0.29%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs